DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

162.38 -5.53 (-3.29%)

REAL-TIME: Last trade at

Extended Hours: $162.38 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

AMGN $162.38 -3.29%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $168.49
Previous Close $167.91
Daily Range $161.55 - $168.72
52-Week Range $108.20 - $173.60
Market Cap $123.2B
P/E Ratio 22.97
Dividend (Yield) $3.16 (1.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,376,888
Average Daily Volume 3,471,384
Current FY EPS $9.49




Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

Biotech Bubble Bursting? 3 Stocks I Want to Buy

Celgene Corporation, Amgen Inc., and Gilead Sciences Inc. may be good biotech stocks to buy on a sell-off.

Why Baird Is Upgrading DaVita Healthcare

Amgen (AMGN) Is Today's Water-Logged And Getting Wetter Stock

The Internet of Things is About to Solve Biotech's Oldest Problem

The field where the Internet of Things is likely to have the biggest impact is often the field no one associates with it: biotech.

Amgen Ticks All The Boxes For A Perfect Investment

Short Sellers Become More Wary of Big Biotech

3 'Safe' Biotech Picks

Massive Energy Trade Highlights High-Profile Insider Selling This Week

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Nasdaq Joins The Record High Club

See More AMGN News...

AMGN's Top Competitors

AMGN $162.38 (-3.29%)
Current stock: AMGN
GILD $102.94 (-0.73%)
Current stock: GILD
CELG $114.72 (-3.37%)
Current stock: CELG
$0.00 (0.00%)
Current stock: